A randomized controlled trial to evaluate the effectiveness of clinical pharmacy service on improving the quality of life and use of medicines in oncology patients at the National Cancer Institute in Sri Lanka.
Not Applicable
- Conditions
- Cancer
- Registration Number
- SLCTR/2020/002
- Lead Sponsor
- Faculty of Medicine, University of Kelaniya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients age 18 years old or above
2. Male and female patients
3. Patients diagnosed with cancer at any stage by an oncologist
4. Patients undergoing their 1st and 2nd cycles of chemotherapy
Exclusion Criteria
1. Patients re-admitted during the study period
2. Patients with poor cognition with no caregiver to manage medicines
3. Patients who unable/unwilling to give informed written consent
4. Patients who already undergone 3rd cycle of chemotherapy onwards
5. Patients who have speech and communication disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The improvement of quality of life (QOL) among patients with oncology as assessed by the mean score difference of EORTC QLQ-C30.<br><br>QOL assessment will be done using standard EORTC QLQ-C30 (version 3.0) questionnaire. The QLQ-C30 questionnaire is a self-administered tool which comprises nine multi-item scales: five functional scales (physical, role, cognitive, emotional, and social); three symptom scales (fatigue, pain, and nausea and vomiting); and a global health and quality-of-life scale.<br> [At their baseline (before starting the chemotherapy cycle), middle of the cycle and at end of the cycle (1 week after the last cycle)]<br>
- Secondary Outcome Measures
Name Time Method